RXRX
Recursion Pharmaceuticals Inc
3.80$
+8.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -3,333.8% | -1,330.2% | -1,586.1% | -210.5% | -655.9% | -610.4% | -497.9% | |
| 145.5% | 115.5% | 84.1% | 29.6% | 55.6% | 62.0% | 112.1% | |
| 80.9% | 125.8% | 148.4% | 70.3% | 121.9% | 138.8% | 148.9% | |
| 80.9% | 200.1% | 197.7% | 99.0% | – | – | – | |
| 23.8% | 903.4% | -3.1% | 264.4% | -100.9% | -64.6% | 18.3% | |
| 228.5% | 197.3% | 398.0% | 94.1% | 27.2% | 23.3% | 8.7% | |
| -228.5% | -256.1% | -2,717.4% | 487.0% | -23.3% | 442.0% | -22.6% | |
| – | – | 4,713.4% | – | – | – | – | |
| 41.2% | 185.3% | -128.0% | -0.2% | -1.7% | -7.5% | -11.3% | |
| 7,037.4% | 7,211.7% | 4,585.4% | 389.0% | 319.4% | 516.9% | 698.3% | |
| 3,475.0% | 5,625.4% | 281.8% | 664.7% | -359.4% | 342.6% | 202.1% | |
| -3,562.4% | -1,527.5% | -1,984.1% | -304.6% | -684.5% | -633.7% | -506.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.